← Leaderboards
Robert Joseph Shmookler-Reis
University Of Arkansas Med Scis Ltl Rock
$3,488,849
Attributed
$4,422,472
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,450,677 · 7
By mechanism
P01$6,862,964 · 4
R01$2,348,544 · 2
P30$239,169 · 1
Top collaborators
- Srinivas Ayyadevara5 shared
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Stavros C. Manolagas$5,168,384
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCaenorhabditis ElegansSiteBaseReportingAge RelatedRna InterferencePathway InteractionsTissuesKnock-DownPeptidesPharmaceutical PreparationsKidneyAspirinPost-Translational Protein ProcessingNon-Steroidal Anti-Inflammatory AgentsDisease ModelNerve DegenerationParkinson DiseaseHeartBrainNeurodegenerative DisordersCharacteristicsCrosslink
Grant awards (22)
Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases$374,971
R01 · FY2022 · AG · contact PI
Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases$374,971
R01 · FY2021 · AG · contact PI
Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases$374,771
R01 · FY2020 · AG · contact PI
Project 3: Models of neurodegenerative aggregate formation$239,722
P01 · FY2020 · AG · contact PI
Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases$372,368
R01 · FY2019 · AG · contact PI
Project 3: Models of neurodegenerative aggregate formation$239,722
P01 · FY2019 · AG · contact PI
Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases$370,165
R01 · FY2018 · AG · contact PI
Project 3: Models of neurodegenerative aggregate formation$239,722
P01 · FY2018 · AG · contact PI
Project 3: Models of neurodegenerative aggregate formation$239,722
P01 · FY2017 · AG · contact PI
Project 3: Models of neurodegenerative aggregate formation$245,980
P01 · FY2016 · AG · contact PI
PILOT/EXPLORATORY STUDIES CORE$239,169
P30 · FY2011 · AG · contact PI
METABOLIC MECHANISMS LIMITING AND PROTECTING LONGEVITY$951,778
P01 · FY2007 · AG · contact PI
GENES AFFECTING METABOLISM AND LONGEVITY IN C. ELEGANS$262,186
P01 · FY2007 · AG · contact PI
RESEARCH MANAGEMENT AND ADMINISTRATION$113,387
P01 · FY2007 · AG · contact PI
METABOLIC MECHANISMS LIMITING AND PROTECTING LONGEVITY$992,062
P01 · FY2006 · AG · contact PI
GENES AFFECTING METABOLISM AND LONGEVITY IN C. ELEGANS$254,318
P01 · FY2006 · AG · contact PI
METABOLIC MECHANISMS LIMITING AND PROTECTING LONGEVITY$994,918
P01 · FY2005 · AG
METABOLIC MECHANISMS LIMITING AND PROTECTING LONGEVITY$1,028,400
P01 · FY2004 · AG
METABOLIC MECHANISMS LIMITING AND PROTECTING LONGEVITY$1,061,047
P01 · FY2003 · AG
POLYMORPHIC GENES MODULATING LIFESPAN IN C ELEGANS$50,000
R01 · FY2002 · AG
POLYMORPHIC GENES MODULATING LIFESPAN IN C ELEGANS$218,836
R01 · FY2001 · AG
POLYMORPHIC GENES MODULATING LIFESPAN IN C ELEGANS$212,462
R01 · FY2000 · AG